Opal Oncology is a single asset company based on a programme that was licensed in from Hershey Cancer Research, USA to develop a novel treatment against Glioblastoma.
Status | Active |
Website | http://www.opalonc.com/ |
Category | Biotech |
Modality | Small Molecule |
Headquaters | Cambridge, UK |
Partner | Business Angels |
Investment Portfolio | Pre-Fund Investment |
Co-Investors | Hershey Cancer Research |